Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Elisabeth Dostal"'
Autor:
Konstantin A Krychtiuk, Stefan P Kastl, Stefan Pfaffenberger, Max Lenz, Sebastian L Hofbauer, Anna Wonnerth, Lorenz Koller, Katharina M Katsaros, Thomas Pongratz, Georg Goliasch, Alexander Niessner, Ludovit Gaspar, Kurt Huber, Gerald Maurer, Elisabeth Dostal, Johann Wojta, Stanislav Oravec, Walter S Speidl
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123367 (2015)
Atherosclerosis is considered to be an inflammatory disease in which monocytes and monocyte-derived macrophages play a key role. Circulating monocytes can be divided into three distinct subtypes, namely in classical monocytes (CM; CD14++CD16-), inter
Externí odkaz:
https://doaj.org/article/577b432d961e453085e302f7971d7033
Autor:
Stefan P. Kastl, Philipp J. Hohensinner, Max Lenz, Johann Wojta, Stanislav Oravec, Kurt Huber, Lore Schrutka, Christian Hengstenberg, Klaus Distelmaier, Konstantin A. Krychtiuk, Elisabeth Dostal, Walter S. Speidl
Publikováno v:
Journal of Clinical Lipidology. 15:512-521
BACKGROUND Proprotein convertase subtilisin/kexin type-9 (PCSK9) is an enzyme promoting the degradation of low-density lipoprotein receptors (LDL-R) in hepatocytes. Inhibition of PCSK9 has emerged as a novel target for lipid-lowering therapy. Monocyt
Publikováno v:
Neuro endocrinology letters. 40(4)
To compare two different analytical methods for determination of small dense LDL and to determine a share of corresponding and non-corresponding (inconsistent) results METHODS: In the group of 104 hyperlipidemic patients and 20 healthy individuals of
Autor:
Martin Schillinger, Kurt Huber, Georg Goliasch, Gerald Maurer, Hermann Blessberger, Matthias Hoke, Franz Wiesbauer, Elisabeth Dostal, Johann Wojta, Stanislav Oravec
Publikováno v:
European Journal of Clinical Investigation. 42:631-636
Eur J Clin Invest 2012; 42 (6): 631–636 Abstract Background Low-density lipoprotein (LDL) cholesterol lowering has been established as one of the principal targets in preventive cardiology. Recently, assessment of LDL particle size and number as we
Autor:
Stanislav Oravec, Kristina Gruber, Andrej Dukat, Peter Gavornik, Ludovit Gaspar, Elisabeth Dostal
Publikováno v:
Lipoproteins-From Bench to Bedside
Research focus: Identification of incidence of an atherogenic lipoprotein pheno‐ type B in four representative diagnoses of cardiovascular diseases: a) arterial hypertension, b) coronary heart disease, c) lower extremity arterial disease, d) ischem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::377f2499f29ede1c3260c018de589ec5
https://doi.org/10.5772/60989
https://doi.org/10.5772/60989
Publikováno v:
Wiener klinisches Magazin. 15:32-34
Zahlreiche Studien haben eindeutig das atherogene Potential des low density Lipoproteins belegt. Die klinische Beobachtung zeigt dennoch, dass viele Patienten mit erhohten LDL-Werten und ohne Therapie entgegen unseren Erwartungen keine kardiovaskular
Autor:
Irene M. Lang, Johann Wojta, Georg Goliasch, Christina Binder, Elisabeth Dostal, Martin Schillinger, Gerald Maurer, Stanislav Oravec, Hermann Blessberger, Kurt Huber, Lore Schrutka, Klaus Distelmaier, Franz Wiesbauer
Publikováno v:
European journal of clinical investigation. 45(7)
Background There is growing evidence that the predictive value of HDL cholesterol levels for cardiovascular risk stratification is limited in patients with coronary artery disease (CAD). HDL function seems to be a more sensitive surrogate of cardiova
Autor:
Elisabeth Dostal, György Járos
Publikováno v:
Systemic Practice and Action Research. 12:195-217
The hierarchical organization (HO) that has provided the prevailing model for business management for most of this century has been challenged repeatedly during the last 20 to 30 years. Matrix Management (MM), Total Quality Management (TQM), and Busi
Publikováno v:
Neuro endocrinology letters. 34(4)
Identification of lipoprotein subfractions in lipoprotein profile by Lipoprint LDL system, where a lipoprotein(a), an independent risk factor for the development of cardiovascular disease, migrates with. The concentration of lipoprotein(a) in serum o
Autor:
Andrej Dukát, Peter Gavorník, Kristína Gruber, Elisabeth Dostal, Stanislav Oravec, Ludovit Gaspar
Publikováno v:
Atherosclerosis. 252:e67